TY - JOUR
T1 - Membrane microviscosity regulates endothelial cell motility
AU - Ghosh, Prabar K.
AU - Vasanji, Amit
AU - Murugesan, Gurunathan
AU - Eppell, Steven J.
AU - Graham, Linda M.
AU - Fox, Paul L.
N1 - Funding Information:
ACKNOWLEDGEMENTS We thank B. Anand-Apte for helpful discussions. This work was supported by National Institutes of Health grants HL/CA54519 and HL29582 to P.L.F. and HL64357 to L.M.G., National Aeronautics and Space Administration grant 96-HEDS-04 to P.L.F. and a Fellowship from the American Heart Association, Ohio Valley Affiliate to P.K.G. Correspondence and requests for material should be addressed to P.L.F.
PY - 2002
Y1 - 2002
N2 - Endothelial cell (EC) movement is an initiating and rate-limiting event in the neogenesis and repair of blood vessels. Here, we explore the hypothesis that microviscosity of the plasma membrane (PM) is a key physiological regulator of cell movement. Aortic ECs treated with membrane-active agents, such as α-tocopherol, cholesterol and lysophospholipids, exhibited a biphasic dependency on membrane microviscosity, in which moderate increases enhanced EC migration, but increases beyond a threshold markedly inhibited migration. Surprisingly, angiogenic growth factors, that is, basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF), also increased membrane microviscosity, as measured in live cells by fluorescence recovery after photobleaching (FRAP). The localization of Rac to the PM was modified in cells treated with membrane-active agents or growth factors, suggesting a molecular mechanism for how membrane microviscosity influences cell movement. Our data show that angiogenic growth factors, as well as certain lipophilic molecules, regulate cell motility through alterations in membrane properties and the consequent relocalization of critical signalling molecules to membranes.
AB - Endothelial cell (EC) movement is an initiating and rate-limiting event in the neogenesis and repair of blood vessels. Here, we explore the hypothesis that microviscosity of the plasma membrane (PM) is a key physiological regulator of cell movement. Aortic ECs treated with membrane-active agents, such as α-tocopherol, cholesterol and lysophospholipids, exhibited a biphasic dependency on membrane microviscosity, in which moderate increases enhanced EC migration, but increases beyond a threshold markedly inhibited migration. Surprisingly, angiogenic growth factors, that is, basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF), also increased membrane microviscosity, as measured in live cells by fluorescence recovery after photobleaching (FRAP). The localization of Rac to the PM was modified in cells treated with membrane-active agents or growth factors, suggesting a molecular mechanism for how membrane microviscosity influences cell movement. Our data show that angiogenic growth factors, as well as certain lipophilic molecules, regulate cell motility through alterations in membrane properties and the consequent relocalization of critical signalling molecules to membranes.
UR - https://www.scopus.com/pages/publications/85006265331
U2 - 10.1038/ncb873
DO - 10.1038/ncb873
M3 - Article
C2 - 12402046
AN - SCOPUS:85006265331
SN - 1465-7392
VL - 4
SP - 894
EP - 900
JO - Nature Cell Biology
JF - Nature Cell Biology
IS - 11
ER -